Heron Therapeutics Stock News

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

Baird Financial Group Inc. bought a new stake in Heron Therapeutics Inc (NASDAQ:HRTX) in the 4th quarter, Holdings Channel.com reports. The firm bought 9,377 shares of the biotechnology company’s st

Man Group plc purchased a new stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The instit

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Brokerages forecast that Heron Therapeutics Inc (NASDAQ:HRTX) will report earnings of ($0.62) per share for the current quarter, according to Zacks Investment Research. Four analysts have issued estim

Analysts forecast that Heron Therapeutics Inc (NASDAQ:HRTX) will announce sales of $20.89 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estima

Great West Life Assurance Co. Can lifted its position in Heron Therapeutics Inc (NASDAQ:HRTX) by 19.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The inst

Amalgamated Bank grew its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 20.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fir

Heron Therapeutics Inc (NASDAQ:HRTX)’s stock price shot up 5.7% during mid-day trading on Tuesday . The stock traded as high as $11.90 and last traded at $11.50, 2,094,109 shares were traded during

How metro Atlanta vets are adapting to provide care for pets amid coronavirus crisis

Credit Suisse AG boosted its holdings in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 154.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and

AlphaCrest Capital Management LLC bought a new stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) during the fourth quarter, according to the company in its most recent filing with the Securities